Paul Horstmeier, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 38,528 shares at $35.96 ($1.4M) on 2020-12-02, disclosed to the SEC on 2020-12-03.
Open-market sale of $1.4M HCAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.99 | 10,650 | $373K | 27.5% |
| 2 | $34.99 | 10,650 | $373K | 27.5% |
| 3 | $35.85 | 100 | $4K | 0.3% |
| 4 | $35.01 | 6,196 | $217K | 16.0% |
| 5 | $35.01 | 6,196 | $217K | 16.0% |
| 6 | $35.96 | 2,368 |
| $85K |
| 6.3% |
| 7 | $35.96 | 2,368 | $85K | 6.3% |
| Total | $35.12 avg | 38,528 | $1.4M | 100% |
| Filing → |
| HCAT | SELL | 2022-03-11 | $587K | — | Filing → |
| HCAT | SELL | 2022-02-09 | $626K | — | Filing → |
| HCAT | SELL | 2022-01-06 | $791K | — | Filing → |